pulmonary hypertension life expectancy with treatment

Patients with pulmonary arterial hypertension (PAH) typically experience an increase in life expectancy following treatment, although the precise duration of life is contingent upon the severity of the disease, the presence of complications, and the individual's response to therapy.

Treatment options for PAH encompass pharmacological interventions, oxygen therapy, and surgical procedures. Pharmacotherapy serves as the primary modality, aiming to alleviate symptoms and enhance quality of life by decreasing pulmonary vascular resistance and improving cardiac function. Oxygen therapy is crucial for patients with hypoxemia, as it can ameliorate hypoxic states and alleviate the strain on the heart. In some cases, patients may require surgery to correct anatomical deformities or undergo lung transplantation.

Beyond undergoing standard treatment, PAH patients must also focus on self-care in their daily routines. This includes maintaining a balanced diet, avoiding overexertion, and regularly monitoring vital signs such as blood pressure and heart rate. Patients should also vigilantly track changes in their condition and seek immediate medical attention if they experience worsening shortness of breath, chest pain, or syncope. Regarding medication, adherence to the physician's instructions is imperative; patients should not alter dosages or discontinue medications without professional guidance to ensure therapeutic efficacy.